ArticleBlood2018
Genetic subtyping of breast implant-associated anaplastic large cell lymphoma.
Abstract readLetter
In one paragraph
Article in Blood, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
58 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- A genetic profiling guideline to support diagnosis and clinical management of lymphomas.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024Guideline
- UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group.British journal of haematology · 2021Guideline
- Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Guideline
- Article
- From molecular pathogenesis to novel Therapeutic approaches - a review of recent advances in the treatment of peripheral T cell Lymphomas.Biomarker research · 2026Review
- Spectrum, pathobiology, mechanistic insights and diagnostic challenges of post-CAR T cell therapy lymphoproliferative disorders.Nature reviews. Clinical oncology · 2026Review
- Beyond the Surface: Deciphering the Role of Genetic Susceptibility in BIA-ALCL Pathogenesis.Biomedicines · 2026Review
- The IL-1R and NFKBIZ pathway mediates immunoregulatory responses and immunotherapy efficacy in anaplastic large cell lymphoma.Leukemia · 2026Article
- Article
- Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art.International journal of molecular sciences · 2024Review
- BIA-ALCL and BIA-SCC: Updates on Clinical Features and Genetic Mutations for Latest Recommendations.Medicina (Kaunas, Lithuania) · 2024Review
- Therapeutic challenges in peripheral T-cell lymphoma.Molecular cancer · 2024Review
- Management of complications following implant-based breast reconstruction: a narrative review.Annals of translational medicine · 2023Review
- Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.Current hematologic malignancy reports · 2023Review
- CD30 Lateral Flow and Enzyme-Linked Immunosorbent Assays for Detection of BIA-ALCL: A Pilot Study.Cancers · 2023Article
- Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.Blood · 2023Article
- A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas.International journal of molecular sciences · 2023Review
- Fibrin-associated large B-cell lymphoma shows frequent mutations related to immune surveillance and PTEN.Blood · 2023Article
- Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop.Virchows Archiv : an international journal of pathology · 2023Article
- Breast Implanted-Associated Anaplastic Large Cell Lymphoma: A Case of Advanced Disease with Flow Cytometric Findings.International journal of surgical pathology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Naoki OishiDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Garry S BrodyDivision of Plastic Surgery, Keck School of Medicine of USC, Los Angeles, CA.
Rhett P KetterlingDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
David S ViswanathaDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Rong HeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Surendra DasariDepartment of Health Sciences Research.
Ming MaiDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Hailey K BensonDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Christopher A SattlerDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Rebecca L BoddickerDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Ellen D McPhailDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
N Nora BennaniDivision of Hematology, and.
Christin A HarlessDivision of Plastic Surgery, Mayo Clinic, Rochester, MN; and.
Kuldeep SinghDivision of Plastic Surgery, Mayo Clinic, Rochester, MN; and.
Mark W ClemensDepartment of Plastic Surgery and.
L Jeffrey MedeirosDepartment of Hematopathology, MD Anderson Cancer Center, Houston, TX.
Roberto N MirandaDepartment of Hematopathology, MD Anderson Cancer Center, Houston, TX.
Andrew L FeldmanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.ORCID 0000-0001-5009-4808
Funding
Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3MThe Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI LENTZ, STEVEN R · 2002 to 2021
$45.7MMayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2MGenetic Biomarkers for Risk Assessment of Peripheral T-Cell LymphomasR01CA177734 · NCI · MAYO CLINIC ROCHESTER · PI FELDMAN, ANDREW LEWIS · 2013 to 2017
$1.6MNCATS NIH HHS UL1 TR000135NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA097274NCI NIH HHS R01 CA177734
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedBreast ImplantsBreast NeoplasmsFemaleGene RearrangementHumansLymphoma, Large-Cell, AnaplasticMiddle AgedNeoplasm ProteinsOncogene Proteins, FusionNeoplasm ProteinsOncogene Proteins, Fusion
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.